Association of the Pro12Ala polymorphism in peroxisome proliferator- activated receptor γ2 with decreased basic metabolic rate in women with polycystic ovary syndrome

European Journal of Endocrinology

Volumn 161, Issue 2, 2009, Pages 317-322

  Koika, Vasiliki ^a   Marioli, Dimitra J ^a   Saltamavros, Alexandros D ^a   Vervita, Vasiliki ^a   Koufogiannis, Kleanthis D ^a   Adonakis, George ^a   Decavalas, George ^a   Georgopoulos, Neoklis A ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; PROLINE; DNA; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TESTOSTERONE;

ADULT; ANOVULATION; ARTICLE; BASAL METABOLIC RATE; BODY MASS; CALORIMETRY; CASE CONTROL STUDY; CHEMOLUMINESCENCE; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HYPERANDROGENISM; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE STUDY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; TESTOSTERONE BLOOD LEVEL; WEIGHT GAIN; BLOOD; CHEMISTRY; GENETIC VARIABILITY; GENETICS; GLUCOSE BLOOD LEVEL; METABOLISM; MISSENSE MUTATION; NONPARAMETRIC TEST; PHYSIOLOGY;

ADULT; BASAL METABOLISM; BLOOD GLUCOSE; CALORIMETRY, INDIRECT; CASE-CONTROL STUDIES; DNA; FEMALE; GENETIC VARIATION; GENOTYPE; HUMANS; INSULIN; INSULIN RESISTANCE; MUTATION, MISSENSE; POLYCYSTIC OVARY SYNDROME; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PPAR GAMMA; STATISTICS, NONPARAMETRIC; TESTOSTERONE; YOUNG ADULT;

EID: 68349132092     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-08-1014     Document Type: Article

References (34)

1. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES & Yildiz BO. The prevalence and features of the polycystic ovarian syndrome in an unselected population. Journal of Clinical Endocrinology and Metabolism 2004 98 2745-2749. (Pubitemid 38766360)
2. Carmina E & Lobo RA. Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. Journal of Clinical Endocrinology and Metabolism 1999 84 1897-1899.
3. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocrine Reviews 1997 18 774-800. (Pubitemid 28009567)
4. Ravussin E, Lillioja S, Knowler WC, Christin L, Freymond D, Abbott WG, Boyce V, Howard BV & Bogardus C. Reduced rate of energy expenditure as a risk factor for body-weight gain. New England Journal of Medicine 1988 318 467-472. (Pubitemid 18054292)
5. Auwerx J. PPARgamma, the ultimate thrifty gene. Diabetologia 1999 42 1033-1049.
6. Yen CJ, Beamer BA, Negri C, Silver K, Brown KA, Yarnall DP, Burns DK, Roth J & Shuldiner AR. Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation. Biochemical and Biophysical Research Communications 1997 241 270-274. (Pubitemid 28020091)
7. Deeb SS, Fajas L, Nemoto M, Pihlajamaki J, Mykkanen L, Kuusisto J, Laakso M, Fujimoto W & Auwerx J. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nature Genetics 1998 20 284-287. (Pubitemid 28507675)
8. Valve R, Sivenius K, Miettinen R, Pihlajamäki J, Rissanen A, Deeb SS, Auwerx J, Uusitura M & Laakso M. Two polymorphisms in the peroxisome proliferator-activated receptor-gamma gene are associated with severe overweight among obese women. Journal of Clinical Endocrinology and Metabolism 1999 84 3708-3712. (Pubitemid 30645229)
9. Hara M, Alcoser SY, Qaadir A, Beiswenger KK, Cox NJ & Ehrmann DA. Insulin resistance is attenuated in women with polycystic ovary syndrome with the Pro(12)Ala polymorphism in the PPARgamma gene. Journal of Clinical Endocrinology and Metabolism 2002 87 772-775. (Pubitemid 34158251)
10. Georgopoulos NA, Saltamavros AD, Vervita V, Karkoulias K, Adonakis G, Decavalas G, Kourounis G, Markou KB & Kyriazopoulou V. Basal metabolic rate is decreased in women with polycystic ovary syndrome and biochemical hyperandrogenemia and is associated with insulin resistance. Fertility and Sterility, 2008. In press. DOI: 10.1016/j.fertnstert.2008.04.067
11. Azziz R, Nestler JE & Dewailly D. Androgen Excess Disorders in Women: Polycystic Ovary Syndrome and Other Disorder, ch 13, pp 146-147. Totowa, NJ, USA: Humana Press 2006.
12. Zawadski JK & Dunaif A. Diagnostic criteria for polycystic ovary syndrome. In Polycystic Ovary Syndrome, pp 377-384. Eds A Dunaif, JR Givens, FP Haseltine & GE Merriam, Boston, MA, USA: Blackwell Scientific, 1992.
13. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group 2004. Revised 2003 consensus on the diagnostic criteria and long term health risks related to polycystic ovary syndrome. Fertility and Sterility 2003 81 19-25. (Pubitemid 38058321)
14. Panidis D, Macut D, Farmakiotis D, Rousso D, Kourtis A, Katsikis I, Spanos N, Petakov M, Bjekic J & Damjanovic S. Indices of insulin sensitivity, beta cell function and serum proinsulin levels in the polycystic ovary syndrome. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2006 127 99-105. (Pubitemid 43947438)
15. Matsuda M & DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999 22 1462-1470. (Pubitemid 29418240)
16. Ferrannini E. The theoretical basis of indirect calorimetry: a review. Metabolism 1988 37 287-301. (Pubitemid 18080935)
17. Norman RJ, Dewailly D, Legro RS & Hickey TE. Polycystic ovary syndrome. Lancet 2007 370 685-697.
18. Halliday D, Hesp R, Stalley SF, Warwick P, Altman DG & Garrow JS. Resting metabolic rate, weight, surface area and body composition in obese women. International Journal of Obesity 1979 3 1-6. (Pubitemid 9130051)
19. James WPT, Davies HL, Bailes J & Dauncey MJ. Elevated metabolic rates in obesity. Lancet 1978 1 1122-1125.
20. Mierhaeghe A & Amouyel P. Impact of genetic variation of PPARγ in humans. Molecular Genetics and Metabolism 2004 83 93-102. (Pubitemid 39311284)
21. Urbanek M, Legro RS, Driscoll DA, Azziz R, Ehrmann DA, Norman RJ, Strauss JF, Spielman RS & Dunaif A. Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. PNAS 1999 96 8573-8578. (Pubitemid 29354833)
22. Ehrmann DA, Tang X, Yoshiuchi I, Cox NJ & Bell GI. Relationship of insulin receptor substrate-1 and -2 genotypes to phenotypic features of polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2002 87 4297-4300. (Pubitemid 34615255)
23. El Mkadem SA, Lautier C, Macari F, Molinari N, Lefèbvre P, Renard E, Gris JC, Cros G, Daurès JP, Bringer J, White MF & Grigorescu F. Role of allelic variants Gly972Arg of IRS-1 and Gly1057Asp of IRS-2 in moderate-to-severe insulin resistance of women with polycystic ovary syndrome. Diabetes 2001 50 2164-2168. (Pubitemid 33643687)
24. Sir-Petermann T, Angel B, Maliqueo M, Santos JL, Riesco MV, Toloza H & Pérez-Bravo F. Insulin secretion in women who have polycystic ovary syndrome and carry the Gly972Arg variant of insulin receptor substrate-1 in response to a high-glycemic or low-glycemic carbohydrate load. Nutrition 2004 20 905-910. (Pubitemid 39330609)
25. Villuendas G, Botella-Carretero JI, Roldán B, Sancho J, Escobar-Morreale HF & San Millán JS. Polymorphisms in the insulin receptor substrate-1 (IRS-1) gene and the insulin receptor substrate-2 (IRS-2) gene influence glucose homeostasis and body mass index in women with polycystic ovary syndrome and non-hyperandrogenic controls. Human Reproduction 2005 20 3184-3191. (Pubitemid 41662676)
26. Hahn S, Fingerhut A, Khomtsiv U, Khomtsiv L, Tan S, Quadbeck B, Herrmann BL, Knebel B, Müller-Wieland D, Mann K & Janssen OE. The peroxisome proliferator-activated receptor gamma Pro12Ala polymorphism is associated with lower hirsutism score and increased insulin sensitivity in women with polycystic ovary syndrome. Clinical Endocrinology 2005 62 573-579. (Pubitemid 40646724)
27. Orio F, Palomba S, Cascella T, Di Biase S, Labella D, Russo T, Savastano S, Zullo F, Colo A, Vettor R & Lombardi G. Lack of association between peroxisome proliferator-activated receptor-γ gene Pro12Ala polymorphism and adiponectin levels in the polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2004 89 5110-5115. (Pubitemid 39391457)
28. San Millan JL, Corton M, Villuendas G, Sancho J, Peral B & Escobar-Morreale HF. Association of the polycystic syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus and obesity. Journal of Clinical Endocrinology and Metabolism 2004 89 2640-2646. (Pubitemid 38766343)
29. Korhonen S, Heinonen S, Hiltunen M, Helisalmi S, Hippelainen M, Koivunen R, Tapanainen JS & Laakso M. Polymorphism in the peroxisome proliferator-activated receptor-g gene in women with polycystic ovary syndrome. Human Reproduction 2003 18 540-543. (Pubitemid 36329321)
30. Tok EC, Aktas A, Ertunc D, Erdal EM & Dilek S. Evaluation of glucose metabolism and reproductive hormones in polycystic ovary syndrome on the basis of peroxisome proliferator-activated receptor (PPAR)-γ2 Pro12Ala genotype. Human Reproduction 2005 20 1590-1595. (Pubitemid 40852253)
31. Yilmaz M, Ali Ergun M, Karakoc A, Yurtcu E, Cakir N & Arslan M. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ gene in women with polycystic ovary syndrome. Gynecological Endocrinology 2006 22 336-342. (Pubitemid 43941411)
32. Beamer BA, Yen CJ, Andersen RE, Muller D, Dariush E, Cheskin LJ, Andres R, Roth J & Shuldiner AR. Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-2 gene with obesity in two Caucasian populations. Diabetes 1998 47 1806-1808. (Pubitemid 28476259)
33. Stumvoll M, Wahl HG, Loblein K, Becker R, Machicao F, Jacob S & Haring H. Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-g2 gene is associated with increased antilipolytic insulin sensitivity. Diabetes 2001 50 876-881. (Pubitemid 32242647)
34. Vidal-Puig AJ, Considine RV, Jimenez-Liñan M, Werman A, Pories WJ, Caro JF & Flier JS. Peroxisome proliferator-activated receptor gene expression in human tissues: effects of obesity, weight loss, and regulation by insulin and glucocorticoids. Journal of Clinical Investigation 1997 99 2416-2422. (Pubitemid 27227719)